Pfizer's stock is poised for growth with strong technical and fundamental indicators, promising pipeline, and Seagen ...
Former executives of the pharmaceutical giant are backing a push by activist investor Starboard Value to turn aro ...
The drugmaker has shed nearly $180 billion in market cap after struggling to chart a new course as the COVID-19 pandemic ...
3don MSN
Starboard has approached two former Pfizer executives, Ian Read and Frank D’Amelio, to assist in its efforts, and they have ...
Authorizing Medicare to cover weight loss drugs would increase federal spending by about $35 billion from 2026 to 2034 ...
GlobalData on MSN3d
Activist investor Starboard forges $1bn stake in Pfizer to swing profitsUS hedge fund Starboard now holds 0.6% of Pfizer’s value as the drugmaker struggles with its post-pandemic financial ...
Activist investor Starboard Value has acquired a $1 billion stake in Pfizer, urging the company to improve its performance.
Pfizer is in value territory, trading at just 10.74X forward earnings with a 5.88% annual dividend yield and over $10 billion in cash after selling $2.4 billion of its HLN position.
Once a top-performing stock thanks to its role in developing the first Covid-19 vaccine, Pfizer has seen its share price drop by nearly half from its 2021 peak.
Current health news highlights WeightWatchers offering a compound version of Novo Nordisk's obesity drug, Danco seeking FDA ...
This report highlights major developments in the health sector, including WeightWatchers offering a new obesity drug, Danco ...
Weight loss treatments are rapidly becoming a focal point for pharma R&D, driven by the commercial success of Eli Lilly and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback